This Company is Investing in the Rapidly Growing Stem Cell Market

By: Dylan Sikes – AllPennyStocks.com News

Monday, March 27, 2023

The global stem cell market is rapidly growing — currently valued at approximately $12 billion with projections to reach approximately $30 billion by 2030. And this firm’s business model is expected to capture significant US market share over the next several years.

Cann American Corp. (OTC PINK:CNNA) previously announced the acquisition of Prodigy Stem Cell, allowing Cann to expand its overall direction as a holding company engaged in alternative therapeutics ranging from CBD to regenerative medicines.

Prodigy plans to offer its product lines to doctors, sports medicine facilities, plastic surgery centers, and similar health and wellness clinics nationwide. This will be achieved through an extensive marketing campaign including conventions and brand ambassadorships. Prodigy has already began to recruit high profile athletes, who are also current clients, to promote the Prodigy brand. The company also plans to rapidly expand into several of its own Prodigy branded wellness centers at strategic locations throughout the U.S.

Shares were trading at $0.018 in mid-morning trade.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.